PatientsLikeMe Pioneers Social Medicine
This article was originally published in Start Up
Executive Summary
The social media site, now in its second decade, has over 350,000 users who report on more than 2,500 diseases. It has begun partnering with biopharma companies eager to engage with members and mine patient-reported data on diseases and outcomes.
You may also be interested in...
How Patients Are Transforming Pharma R&D
Patient-centric R&D is imperative for pharma in delivering effective medicines and better outcomes. The push to implement it is challenging long-held biopharma business practices, including how clinical trials are designed, recruited and run – and what they measure.
The Shrinking Value Of Best-In-Class And First-In-Class Drugs
Incumbency ain’t worth what it once was. Pharma companies are spending billions to create advantages that won’t have significant lasting power. Smart followers can do as well – for less.
Can Google Enhance Drug Safety Surveillance?
Teleconference between company and FDA signals the Internet search giant may have a way to improve adverse event detection.